Does methotrexate increase the risk of varicella or herpes zoster infection in patients with rheumatoid arthritis A systematic literature review
Review
infection in patients with rheumatoid arthritis?
A systematic literature review
11122
1
Cambridge, Cambridge, United Kingdom;School of Clinical Medicine, University of 2
Addenbrooke’Rheumatology Research Unit,
Cambridge, United Kingdom.s Hospital, CUHNHSFT, Natalie Zhang*Sarah Wilkinson*Mehmood RiazAndrew J.K. ÖstörMuhammad K. Nisar
*these authors are co- rst authors having contributed equally to the manuscript.Please address correspondence to: Dr Muhammad Nisar,
Rheumatology Research Unit, Box 194, Addenbrooke’Cambridge CB2 2QQ, United Kingdom.s Hospital, CUHNHSFT, E-mail: drnisar12@yahoo.co.uk
Received on March 1, 2012; accepted in revised form on July 12, 2012.
Clin Exp Rheumatol 2012; 30: 962-971.© Copyright EXPERIMENTALCLINICAL RHEUMATOLOGY AND
2012.
Key words:methotrexate, varicella zoster, herpes rheumatoid arthritis, zoster, shingles, chickenpox, vaccination
Competing interests: A. Östör has received support from (including attendance at conferences), undertakes clinical trials and acts as a consultant to Roche, Chugai, Schering-Plough/MSD, Abbott, Wyeth, BMS, GSK, MerckSorono and UCB; the other co-authors have declared no competing interests.
ABSTRACT
Introduction. become the foundation disease-modify-Methotrexate (MTX) has ing anti-rheumatic drug (DMARD) for RA. ing its possible association with infec-However, concern exists regard-tious complications including varicella zoster (HZ). virus (VZV) and herpes ists regarding pre-MTX VZV screening Furthermore, no consensus zoster ex-or the use of VZV vaccine.
Methods. erature relationship between the use of MTX in review We undertook systematic lit-(SLR) investigating the patients with RA and VZV and HZ infec-tion. Additionally, the European Centre for HPDisease Prevention and Control, and A, the CDC, Rheumatology societies were consulted.
WHO web sites and publications Results. inclusion criteria comprising 29 obser-Thirty- ve studies ful lled the vational studies and 6 case reports. The case reports and 13 observation stud-ies considered the association between MTX and HZ. Three of the observation-al studies reported a positive associa-tion although in 5 cases, patients were concurrently treated with prednisolone. Five studies concluded that there was no association between HZ and MTX. Three rates of MTX with other RA therapies studies comparing the infection found that MTX did not result in higher HZ infection rates. Three studies exam-ining the association between HZ and MTX treatment duration failed to show a link.
Conclusion. port an association between MTX and No evidence exists to sup-VZV data regarding the role of MTX in HZ infection in RA patients and the development is con icting. The role of pre-MTX sial VZV screening is RA treatment, we suggest against VZVand, as it may delay initiation controver-of screening in this context.
962
Introduction
Rheumatoid temic autoimmune disease of unknown arthritis (RA) is a sys-aetiology world’s affecting up to 1% of the has last decade with appropriate use of tra-improved population tremendously (1). The prognosis over the ditional and biologic DMARDs (2, 3). Due to its ef cacy, safety and tolerabil-ity, DMARD for RA (4, 5).
MTX has become the foundation Historically, effective doses of MTX existed due to a reluctance to prescribe concerns potential regarding its tolerability and complications, including varicella zoster association with infectious virus (VZV) (6). Its origin as a chemo-therapeutic agent may have contributed to this belief (7). An incidence of 8% of VZV on maintenance MTX treatment follow-infections in leukaemia patients ing has intensive contribution of MTX on VZV infection been seen induction (8). However, chemotherapy the sole risk in these patients is dif cult to de- ne due to the nature of the underlying pathology, the diversity of chemothera-peutic regimens and the degree of im-munosuppression. Conversely failure to prescribe adequate doses of MTX in RA patients mation, ongoing immune dysregulation may lead to persistent in am-and infection as a result.
potentially a higher likelihood of It is unclear whether the relatively low doses of MTX used to treat rheumatic diseases MTX has been shown to suppress pro-are immunosuppressive (9). in ammatory cytokines, such as IFN-γ, that play an important role in the host’s initial innate response to VZV (10, 11). Other activity proposed mechanisms of glutathione include ity, and reduced MTX macrophage intracellular cells (12, 13), suppression of neutrophil
increased apoptosis of activated activ-T
With increasing time after varicella infection, ...herpes zoster,7 although such testing does not ...(CNS) vasculopathy; evidence of an increase in ...
varicella (chicken pox) as a primary infection, ... does not possess the sensitivity necessary to ...of varicella-zoster virus and herpes simplex virus...
risk of miscarriage, although in some cases such infection can Disseminated ...herpes zoster; the only medical history of interest was maternal varicella ...
herpes simplex virus type 2 and varicella-zoster ...(2000b) reported a 22% increase in the ...Infection 2000;28:85– 91. Storch GA. ...
varicella-zoster virus acquired during the primary varicella infection, or ... and radiation therapy may increase the risk of developing herpes zoster. ...
Herpes Simplex Herpes Simplex Viral infection either... Shingles, a reactivation of varicella zoster (...ointment or methotrexate Sebaceous Cysts Sebaceous ...
herpes simplex virus type 2 and varicella-zoster ...(2000b) reported a 22% increase in the ...Infection 2000;28:85– 91. Storch GA. ...
热门文档